Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-12-059959

← back to feed
Filed
Nov 7, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 7, 2012 21.63M sh
Stockholders Equity Q3 2012 · Sep 30, 2012 −$1.35M
Stockholders Equity Q3 2012 · Dec 31, 2011 −$124.03K
Current Liabilities Q3 2012 · Sep 30, 2012 $2.23M
Current Liabilities Q3 2012 · Dec 31, 2011 $2.31M
Current Assets Q3 2012 · Sep 30, 2012 $879.67K
Current Assets Q3 2012 · Dec 31, 2011 $2.18M
Total Assets Q3 2012 · Sep 30, 2012 $884.66K
Total Assets Q3 2012 · Dec 31, 2011 $2.19M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$1.27M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $2.46M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $3.52M
Sga Expense Q3 2012 · Sep 30, 2011 $227.27K
Sga Expense Q3 2012 · Sep 30, 2011 $896.61K
Rd Expense Q3 2012 · Sep 30, 2011 $457.19K
Rd Expense Q3 2012 · Sep 30, 2011 $799.18K
Operating Income Q3 2012 · Sep 30, 2011 −$684.46K
Operating Income Q3 2012 · Sep 30, 2011 −$1.7M
Revenue Q3 2012 · Sep 30, 2011 $0
Revenue Q3 2012 · Sep 30, 2011 $0